Publications
Advancing knowledge in chronic liver disease through evidence-based research.
AbstractsPublication policy

Showing 10 of 271 papers

Fibroblast growth factor 21 is an early predictor of acute-on-chronic liver failure in critically ill patients with cirrhosis

Ruiz-Margáin A, Pohlmann A, Ryan P, Schierwagen R, Chi-Cervera LA, Jansen C, Mendez-Guerrero O, Flores-García NC, Lehmann J, Torre A, Macías-Rodríguez RU, Trebicka J.

Liver Transpl 2018, 24(5): 595–605

DOI: 10.1002/lt.25041

Severe abnormal heart rate turbulence onset is associated with deterioration of liver cirrhosis

Jansen C, Al-Kassou B, Lehmann J, Pohlmann A, Chang J, Praktiknjo M, Nickenig G, Strassburg CP, Schrickel JW, Andrié R, Linhart M, Trebicka J.

PLoS One 2018, 13(4): e0195631

DOI: 10.1371/journal.pone.0195631

Return-to-health effect of modern combined antiretroviral therapy potentially predisposes HIV patients to hepatic steatosis

Mohr R, Boesecke C, Dold L, Schierwagen R, Schwarze-Zander C, Wasmuth JC, Weisensee I, Rockstroh JK, Trebicka J.

Medicine 2018, 97(17): e0462

DOI: 10.1097/MD.0000000000010462

“Tipping” extracellular matrix remodeling towards regression of liver fibrosis: Novel concepts

Magdaleno F, Schierwagen R, Uschner FE, Trebicka J.

Minerva Gastroenterol Dietol 2018, 64(1): 51–61

DOI: 10.23736/S1121-421X.17.02442-4

Cell death markers in patients with cirrhosis and acute decompensation

Macdonald S, Andreola F, Bachtiger P, Amoros A, Pavesi M, Mookerjee R, Zheng YB, Gronbaek H, Gerbes AL, Sola E, Caraceni P, Moreau R, Gines P, Arroyo V, Jalan R.

Hepatology 2018, 67(3): 989–1002

DOI: 10.1002/hep.29581

Evolution of nodule stiffness might predict response to local ablative therapy: A series of patients with hepatocellular carcinoma

Praktiknjo M, Krabbe V, Pohlmann A, Sampels M, Jansen C, Meyer C, Strassburg CP, Trebicka J, Gonzalez Carmona MA.

PLoS One 2018, 13(2): e0192897

DOI: 10.1371/journal.pone.0192897

Does transjugular intrahepatic portosystemic shunt stent differentially improve survival in a subset of cirrhotic patients?

Trebicka J.

Semin Liver Dis 2018, 38(1): 87–96

DOI: 10.1055/s-0038-1627457

Acute decompensation boosts hepatic collagen type III deposition and deteriorates experimental and human cirrhosis

Praktiknjo M, Lehmann J, Nielsen MJ, Schierwagen R, Uschner FE, Meyer C, Thomas D, Strassburg CP, Bendtsen F, Møller S, Krag A, Karsdal MA, Leeming DJ, Trebicka J

Hepatol Commun 2018, 2(2): 211–222

DOI: 10.1002/hep4.1135

Exposure to previous cART is associated with significant liver fibrosis and cirrhosis in human immunodeficiency virus-infected patients

Anadol E, Lust K, Boesecke C, Schwarze-Zander C, Mohr R, Wasmuth JC, Rockstroh JK, Trebicka J.

PLoS One 2018, 13(1): e0191118

DOI: 10.1371/journal.pone.0191118

Assessment of biopsy-proven liver fibrosis by two-dimensional shear wave elastography: An individual patient data-based meta-analysis

Herrmann E, de Lédinghen V, Cassinotto C, Chu WC, Leung VY, Ferraioli G, Filice C, Castera L, Vilgrain V, Ronot M, Dumortier J, Guibal A, Pol S, Trebicka J, Jansen C, Strassburg C, Zheng R, Zheng J, Francque S, Vanwolleghem T, Vonghia L, Manesis EK, Zoumpoulis P, Sporea I, Thiele M, Krag A, Cohen-Bacrie C, Criton A, Gay J, Deffieux T, Friedrich-Rust M.

Hepatology 2018, 67(1): 260–272

DOI: 10.1002/hep.29179